Navigation Links
Nile Therapeutics Completes Dosing of Phase II Study
Date:7/7/2010

SAN FRANCISCO, July 7 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced that it has completed the dosing of the last patient in NIL-CDNP-CT005, an open-label, single-blind, placebo-controlled Phase II study of CD-NP in patients with acute decompensated heart failure, or ADHF. The study was designed to provide additional information on the safety and tolerability of CD-NP when infused for up to 72 hours in patients with ADHF and mild to moderate renal insufficiency.  Additional endpoints included assessments of symptom relief and effects on biomarkers of heart failure and renal function.  

"We are very pleased with the progress of this trial and look forward to reviewing the final clinical data. We are also very proud and impressed with the hard work of the clinical sites and investigators.  Nile looks forward to building upon these relationships and the experience gained from this trial to optimally design and execute our future studies," said Hsiao D. Lieu, M.D. VP of Clinical Research for Nile.

In total, 77 patients were randomized into six cohorts at one of four doses of CD-NP (1.25, 2.5, 3.75 and 5 ng/kg/min) or placebo. Two cohorts were enrolled at each of the 1.25 and 2.5 ng/kg/min dose levels, which preliminary data suggest are the doses with the most attractive clinical profile to investigate in future ADHF studies.  Over 35% of patients were enrolled in the U.S., with the remaining patients enrolled in Israel and Germany. Nile expects the last
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015 Boston Scientific Corporation (NYSE: ... J. Dockendorff and Stephen P. MacMillan to ... members of the board, Uwe E. Reinhardt and ... at the company,s annual meeting of stockholders in May 2015. ... the executive vice president and chief financial officer of Covidien ...
(Date:3/3/2015)... Ky. , March 3, 2015 Dr. ... Louisville,s greatest leaders in aesthetics. In addition ... Brownsboro Plastic and Hand Surgery practice, Dr. Cummins now ... Louisville Tattoo Removal clinic . Dr. Cummins performs all ... "I founded Louisville Tattoo Removal in order to ...
(Date:3/3/2015)... /CNW/ - The issue: Health ... at Art Nails Ltd., located at 751 Helmcken St., ... contained no labelling. All products administered by injection in ... have approved labelling. The store owner claimed ... risks associated with injecting an unauthorized version of a health product ...
Breaking Medicine Technology:Boston Scientific Elects Charles J. Dockendorff And Stephen P. MacMillan To Board Of Directors 2Surgeon Owned And Operated Louisville Tattoo Removal Offers Astanza Duality Laser Treatments 2Advisory - Health product seized from Art Nails in Vancouver 2
... 21, 2007-- Serotonin is a,neurotransmitter that helps ... to determine the role of serotonin in,patients ... 48 females --,including individuals with IBS, individuals ... and healthy volunteers.,Biopsies were obtained from the ...
... MADISON, N.J., May 9 /PRNewswire-FirstCall/ -- Wyeth (NYSE: ... Administration's (FDA),San Juan District Office has informed the ... Puerto Rico manufacturing,facility has resulted in a positive ... that any issues found by the FDA have,either ...
Cached Medicine Technology:FDA Re-Inspection Results in Positive Re-Classification of Guayama,Facility 2FDA Re-Inspection Results in Positive Re-Classification of Guayama,Facility 3
(Date:3/4/2015)... 04, 2015 The medical device landscape ... management forgot – or ignored or didn't know – ... market based on physician input before proceeding to design ... specifically, founders – become so enamored of an innovative ... Will physicians use the device?” says Dr. Kathryn ...
(Date:3/3/2015)... 2015 On February 24, 2015, a ... United States District Court for the Northern District of ... well as insurance companies Balboa, QBE, and Newport Management. ... No. 3:14-cv-152.) , The Plaintiff, a Ms. Dolores Gorsuch, ... force her to buy too much insurance at rates ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Longtime parent ... with CARE Surrogacy Center for a candid ... originally appearing online is an exhilarating revelation of his ... have led him from Australia to the birth of ... press interchange, Tolga Umar, CEO and Founder of CARE ...
(Date:3/3/2015)... March 03, 2015 Dan E. Chambers, an ... special focus on capital crimes, recently spoke on the radio ... trial. The hosts of the Independent Journal Review radio show ... working first as a prosecutor and now as a criminal ... decisions made in the trial and sentencing of this high-profile ...
(Date:3/3/2015)... 04, 2015 The report “Alopecia – ... therapeutic development for Alopecia. Alopecia is the loss of ... main types of alopecia. Causes for alopecia include aging, ... alopecia may include male pattern hair loss, female diffuse ... can be classified as focal or diffuse and by ...
Breaking Medicine News(10 mins):Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 2Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 3Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 2Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 3Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 4
... ... technology shows its latest UV-LED curing systems for UV printing applications in Guangzhou. , ... (PRWEB) March 8, 2010 -- Printing ... evolution of UV-LED curing technology from Phoseon for UV printing applications . The Phoseon ...
... three early-stage breast cancer patients who received genomic testing ... fully understand their discussions with physicians about their test ... four experienced distress when receiving their test results. ... of the American Cancer Society, the findings suggest there ...
... ... ... , , ... WASHINGTON , March ...
... ... Sponsors for the 2010 Cinco de Mayo Half Marathon and the 12th Annual “Reaching for ... ... Pediatric Cancer Research Foundation (PCRF) announced the official sponsors for the annual “Reaching for ...
... ... ... ... ...
... tips to prevent early tooth decay, damage , SATURDAY, March ... children,s teeth a healthy start is to begin dental care ... for keeping kids, teeth in tip-top shape: , Visit ... six months of the eruption of a child,s first tooth, ...
Cached Medicine News:Health News:Phoseon Technology Continues Worldwide Rollout of UV-LED Curing Systems with Attendance at Printing South China 2010 2Health News:Improvements needed in genomic test result discussions 2Health News:Illinois State Senator Cullerton Recognized for Advocacy Work on Mental Health Issues 2Health News:Illinois State Senator Cullerton Recognized for Advocacy Work on Mental Health Issues 3Health News:Illinois State Senator Cullerton Recognized for Advocacy Work on Mental Health Issues 4Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 2Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 3Health News:The Pentagon Tragedy: Mental Illness, Violence and What Reporters Should Ask 2Health News:The Pentagon Tragedy: Mental Illness, Violence and What Reporters Should Ask 3Health News:The Pentagon Tragedy: Mental Illness, Violence and What Reporters Should Ask 4Health News:The Pentagon Tragedy: Mental Illness, Violence and What Reporters Should Ask 5Health News:Protect Your Baby's Smile 2
... patented Orion incorporates superior optics in a ... The fully adjustable headband, made of white ... on the brow, directing the spot along ... on the headband position the cable diagonally ...
... Bring the clarity of daylight into the ... Light Source. Designed for a variety of ... instruments, and video equipment - this light ... 300 watts (6,000o K) for superb tissue ...
CO 2 SMO-Capnograph/Pulse Oximeter...
... for an emergency situation, bedside monitoring or ... / Pulse Oximeter delivers accurate SpO 2 ... handheld monitor now contains Nellcors latest OxiMax ... OxiMax sensors. The NPB-75 monitor also features ...
Medicine Products: